Showing results (341-350 of 630) with videos related to
Sort By:
Pageof 63
The British Journal of Dermatology|October 5, 2021
Psychometric validation and responder definition of the sleep disturbance numerical rating scale in moderate-to-severe atopic dermatitisJ Puelles, F Fofana, D Rodriguez, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|April 24, 2022
High threshold efficacy responses in moderate-to-severe atopic dermatitis are associated with additional quality of life benefits: pooled analyses of abrocitinib monotherapy studies in adults and adolescentsS Ständer, N Bhatia, M J Gooderham, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|March 13, 2019
Optimization of placebo use in clinical trials with systemic treatments for atopic dermatitis: an International Eczema Council survey-based position statementY A Leshem, R Bissonnette, C Paul, et al.The British Journal of Dermatology|April 12, 2019
Validation of five patient-reported outcomes for atopic dermatitis severity in adultsJ I Silverberg, D J Margolis, M Boguniewicz, et al.Dermatitis : Contact, Atopic, Occupational, Drug|September 27, 2023
Assessment and Management of Sleep Disturbances in Atopic Dermatitis: A ReviewArchana Samynathan, Anna B Fishbein, Sabra M Abbott, et al.American Journal of Clinical Dermatology|April 7, 2021
Extended Safety Analysis of Baricitinib 2 mg in Adult Patients with Atopic Dermatitis: An Integrated Analysis from Eight Randomized Clinical TrialsBrett King, Catherine Maari, Edward Lain, et al.The British Journal of Dermatology|July 28, 2021
Association between atopic dermatitis and hypertension: a systematic review and meta-analysisM Yousaf, M Ayasse, A Ahmed, et al.Dermatology and Therapy|October 23, 2018
Crisaborole Ointment Improves Quality of Life of Patients with Mild to Moderate Atopic Dermatitis and Their FamiliesEric L Simpson, Amy S Paller, Mark Boguniewicz, et al.Dermatology and Therapy|November 30, 2021
Clinical Tailoring of Baricitinib 2 mg in Atopic Dermatitis: Baseline Body Surface Area and Rapid Onset of Action Identifies Response at Week 16Jonathan I Silverberg, Mark Boguniewicz, Jill Waibel, et al.The British Journal of Dermatology|February 8, 2020
Basal cell carcinoma: an emerging epidemic in women in IcelandJ A Adalsteinsson, D Ratner, E Olafsdóttir, et al.Pageof 63